United Therapeutics Corp (NAS:UTHR)
$ 265.91 4.96 (1.9%) Market Cap: 11.80 Bil Enterprise Value: 9.48 Bil PE Ratio: 12.58 PB Ratio: 2.20 GF Score: 89/100

United Therapeutics Corp at Wedbush PacGrow Healthcare Virtual Conference Transcript

Aug 11, 2020 / 12:00PM GMT
Release Date Price: $109.15 (-1.60%)
Vasiliana Vireen Moussatos
Wedbush Securities Inc., Research Division - MD of Equity Research

Good morning. Thank you very much for joining us at the 2020 Virtual Wedbush Healthcare Conference. My name is Liana Moussatos, and I'm one of the senior healthcare analysts at Wedbush. Dewey, would you like to read the forward-looking statement, please?

Dewey Steadman
United Therapeutics Corporation - Head of IR

Good morning. Our remarks today may include forward-looking information about our business. And please see our SEC filings for risks and uncertainties that could cause actual results to differ. Thank you.

Vasiliana Vireen Moussatos
Wedbush Securities Inc., Research Division - MD of Equity Research

It is my pleasure to introduce our first presenting company, United Therapeutics. When I think about United Therapeutics, I think about a well-run pharmaceutical company having growth by innovation. Today, we are joined by the CEO, Martine Rothblatt; Chief Financial Officer, James Edgemond; and Head of IR, Dewey

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot